Anti-oxidized macrophage migration inhibitory factor (oxMIF) antibody imalumab (BAX69) in advanced solid tumors: Final results of first-in-human phase 1 study - Mahalingam, Devalingam; Halama, Niels; Jäger, Dirk (Annals of oncology, 2016)
Gesehen am 10.11.2017